hardcover. Condition: Very Good. Pages are clean with no markings.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 174.00
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 173.99
Quantity: 8 available
Add to basketCondition: New.
Language: English
Published by John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Hardback. Condition: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
US$ 195.35
Quantity: 3 available
Add to basketCondition: New. pp. 336.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 192.50
Quantity: 8 available
Add to basketCondition: As New. Unread book in perfect condition.
Seller: Chiron Media, Wallingford, United Kingdom
US$ 196.95
Quantity: 8 available
Add to basketHardcover. Condition: New.
US$ 207.59
Quantity: 3 available
Add to basketCondition: New. pp. 616.
Condition: New. pp. 336.
Language: English
Published by John Wiley & Sons Inc, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
US$ 196.92
Quantity: 8 available
Add to basketHardback. Condition: New. New copy - Usually dispatched within 4 working days.
Language: English
Published by John Wiley & Sons Inc, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
US$ 226.34
Quantity: Over 20 available
Add to basketCondition: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . .
Condition: New. pp. 616.
Language: English
Published by John Wiley & Sons Inc, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: Revaluation Books, Exeter, United Kingdom
US$ 254.46
Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock.
Language: English
Published by John Wiley & Sons Inc, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . . Books ship from the US and Ireland.
Language: English
Published by John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: Rarewaves.com UK, London, United Kingdom
US$ 197.89
Quantity: 4 available
Add to basketHardback. Condition: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Neuware - This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward.The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Language: English
Published by John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
First Edition Print on Demand
Hardcover. Condition: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Language: English
Published by John Wiley & Sons Inc, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
US$ 205.07
Quantity: Over 20 available
Add to basketHardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 1029.
Language: English
Published by John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: CitiRetail, Stevenage, United Kingdom
First Edition Print on Demand
US$ 186.23
Quantity: 1 available
Add to basketHardcover. Condition: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Language: English
Published by John Wiley & Sons Inc, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: Revaluation Books, Exeter, United Kingdom
US$ 232.01
Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock. This item is printed on demand.
Language: English
Published by John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Seller: AussieBookSeller, Truganina, VIC, Australia
First Edition Print on Demand
Hardcover. Condition: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.